Extended Data Table 2 Data collection and refinement statistics for the BRAFKD–belvarafenib complex

From: ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma

  1. One crystal used for each dataset. *Values in parentheses are for the highest-resolution shell.